nodes	percent_of_prediction	percent_of_DWPC	metapath
Pioglitazone—PTGS1—esophageal cancer	0.553	1	CbGaD
Pioglitazone—SLCO1B3—Methotrexate—esophageal cancer	0.105	0.421	CbGbCtD
Pioglitazone—SLCO1B1—Methotrexate—esophageal cancer	0.0611	0.245	CbGbCtD
Pioglitazone—CYP2C9—Capecitabine—esophageal cancer	0.0551	0.222	CbGbCtD
Pioglitazone—CYP2C9—Cisplatin—esophageal cancer	0.0278	0.112	CbGbCtD
Pioglitazone—Rosiglitazone—CYP2A6—esophageal cancer	0.00279	0.566	CrCbGaD
Pioglitazone—Rosiglitazone—PTGS1—esophageal cancer	0.00214	0.434	CrCbGaD
Pioglitazone—Congenital anomaly—Capecitabine—esophageal cancer	0.00189	0.0256	CcSEcCtD
Pioglitazone—Developmental delay—Capecitabine—esophageal cancer	0.00189	0.0256	CcSEcCtD
Pioglitazone—Tooth abscess—Capecitabine—esophageal cancer	0.00172	0.0233	CcSEcCtD
Pioglitazone—Generalised oedema—Cisplatin—esophageal cancer	0.00163	0.0222	CcSEcCtD
Pioglitazone—Diabetic—Methotrexate—esophageal cancer	0.0016	0.0217	CcSEcCtD
Pioglitazone—Transient ischaemic attack—Capecitabine—esophageal cancer	0.00142	0.0193	CcSEcCtD
Pioglitazone—Visual acuity reduced—Capecitabine—esophageal cancer	0.0012	0.0163	CcSEcCtD
Pioglitazone—Infection—Carboplatin—esophageal cancer	0.00117	0.0159	CcSEcCtD
Pioglitazone—Fluid retention—Cisplatin—esophageal cancer	0.000923	0.0125	CcSEcCtD
Pioglitazone—Multiple fractures—Methotrexate—esophageal cancer	0.000918	0.0124	CcSEcCtD
Pioglitazone—Fracture—Methotrexate—esophageal cancer	0.000918	0.0124	CcSEcCtD
Pioglitazone—Myocardial ischaemia—Capecitabine—esophageal cancer	0.000892	0.0121	CcSEcCtD
Pioglitazone—Polyp—Methotrexate—esophageal cancer	0.000877	0.0119	CcSEcCtD
Pioglitazone—Proteinuria—Capecitabine—esophageal cancer	0.000816	0.0111	CcSEcCtD
Pioglitazone—Protein urine present—Capecitabine—esophageal cancer	0.000804	0.0109	CcSEcCtD
Pioglitazone—Cyst—Methotrexate—esophageal cancer	0.000798	0.0108	CcSEcCtD
Pioglitazone—Liver disorder—Methotrexate—esophageal cancer	0.000783	0.0106	CcSEcCtD
Pioglitazone—Cardiac failure congestive—Cisplatin—esophageal cancer	0.000778	0.0105	CcSEcCtD
Pioglitazone—Cerebrovascular accident—Cisplatin—esophageal cancer	0.00072	0.00976	CcSEcCtD
Pioglitazone—Fluid retention—Capecitabine—esophageal cancer	0.00068	0.00922	CcSEcCtD
Pioglitazone—Neoplasm—Capecitabine—esophageal cancer	0.000648	0.00878	CcSEcCtD
Pioglitazone—Breast disorder—Cisplatin—esophageal cancer	0.000638	0.00865	CcSEcCtD
Pioglitazone—Abnormal vision—Capecitabine—esophageal cancer	0.000625	0.00847	CcSEcCtD
Pioglitazone—Proteinuria—Methotrexate—esophageal cancer	0.000607	0.00823	CcSEcCtD
Pioglitazone—Protein urine present—Methotrexate—esophageal cancer	0.000599	0.00812	CcSEcCtD
Pioglitazone—Diabetes mellitus—Capecitabine—esophageal cancer	0.000598	0.00811	CcSEcCtD
Pioglitazone—Gastroenteritis—Capecitabine—esophageal cancer	0.000587	0.00796	CcSEcCtD
Pioglitazone—Hepatic failure—Capecitabine—esophageal cancer	0.000579	0.00785	CcSEcCtD
Pioglitazone—Hepatic enzyme increased—Methotrexate—esophageal cancer	0.000564	0.00765	CcSEcCtD
Pioglitazone—Increased appetite—Capecitabine—esophageal cancer	0.000554	0.00751	CcSEcCtD
Pioglitazone—Acute coronary syndrome—Cisplatin—esophageal cancer	0.000536	0.00727	CcSEcCtD
Pioglitazone—Myocardial infarction—Cisplatin—esophageal cancer	0.000533	0.00723	CcSEcCtD
Pioglitazone—Cardiac failure—Capecitabine—esophageal cancer	0.000533	0.00723	CcSEcCtD
Pioglitazone—Cerebrovascular accident—Capecitabine—esophageal cancer	0.000531	0.0072	CcSEcCtD
Pioglitazone—Pain in extremity—Capecitabine—esophageal cancer	0.00052	0.00705	CcSEcCtD
Pioglitazone—Neoplasm—Methotrexate—esophageal cancer	0.000482	0.00654	CcSEcCtD
Pioglitazone—Urinary tract disorder—Cisplatin—esophageal cancer	0.000482	0.00654	CcSEcCtD
Pioglitazone—Liver function test abnormal—Capecitabine—esophageal cancer	0.00048	0.00651	CcSEcCtD
Pioglitazone—Connective tissue disorder—Cisplatin—esophageal cancer	0.00048	0.0065	CcSEcCtD
Pioglitazone—Urethral disorder—Cisplatin—esophageal cancer	0.000479	0.00649	CcSEcCtD
Pioglitazone—Abdominal pain upper—Capecitabine—esophageal cancer	0.000475	0.00644	CcSEcCtD
Pioglitazone—Pulmonary oedema—Methotrexate—esophageal cancer	0.000475	0.00644	CcSEcCtD
Pioglitazone—Visual impairment—Cisplatin—esophageal cancer	0.00047	0.00638	CcSEcCtD
Pioglitazone—Breast disorder—Capecitabine—esophageal cancer	0.00047	0.00637	CcSEcCtD
Pioglitazone—Alanine aminotransferase increased—Capecitabine—esophageal cancer	0.000459	0.00622	CcSEcCtD
Pioglitazone—Eye disorder—Cisplatin—esophageal cancer	0.000456	0.00619	CcSEcCtD
Pioglitazone—Cardiac disorder—Cisplatin—esophageal cancer	0.000453	0.00614	CcSEcCtD
Pioglitazone—Influenza—Capecitabine—esophageal cancer	0.00045	0.0061	CcSEcCtD
Pioglitazone—Diabetes mellitus—Methotrexate—esophageal cancer	0.000445	0.00604	CcSEcCtD
Pioglitazone—Immune system disorder—Cisplatin—esophageal cancer	0.000441	0.00598	CcSEcCtD
Pioglitazone—Mediastinal disorder—Cisplatin—esophageal cancer	0.00044	0.00596	CcSEcCtD
Pioglitazone—Angina pectoris—Capecitabine—esophageal cancer	0.000438	0.00594	CcSEcCtD
Pioglitazone—Bronchitis—Capecitabine—esophageal cancer	0.000432	0.00586	CcSEcCtD
Pioglitazone—Hepatic failure—Methotrexate—esophageal cancer	0.000431	0.00584	CcSEcCtD
Pioglitazone—Malnutrition—Cisplatin—esophageal cancer	0.000425	0.00576	CcSEcCtD
Pioglitazone—Flatulence—Cisplatin—esophageal cancer	0.000419	0.00568	CcSEcCtD
Pioglitazone—Upper respiratory tract infection—Capecitabine—esophageal cancer	0.000418	0.00566	CcSEcCtD
Pioglitazone—Weight increased—Capecitabine—esophageal cancer	0.000409	0.00555	CcSEcCtD
Pioglitazone—Visual disturbance—Methotrexate—esophageal cancer	0.000409	0.00554	CcSEcCtD
Pioglitazone—Muscle spasms—Cisplatin—esophageal cancer	0.000409	0.00554	CcSEcCtD
Pioglitazone—Weight decreased—Capecitabine—esophageal cancer	0.000407	0.00551	CcSEcCtD
Pioglitazone—Hyperglycaemia—Capecitabine—esophageal cancer	0.000406	0.0055	CcSEcCtD
Pioglitazone—Infestation NOS—Capecitabine—esophageal cancer	0.000401	0.00543	CcSEcCtD
Pioglitazone—Infestation—Capecitabine—esophageal cancer	0.000401	0.00543	CcSEcCtD
Pioglitazone—Acute coronary syndrome—Capecitabine—esophageal cancer	0.000395	0.00536	CcSEcCtD
Pioglitazone—Cerebrovascular accident—Methotrexate—esophageal cancer	0.000395	0.00536	CcSEcCtD
Pioglitazone—Ill-defined disorder—Cisplatin—esophageal cancer	0.000394	0.00535	CcSEcCtD
Pioglitazone—Myocardial infarction—Capecitabine—esophageal cancer	0.000393	0.00533	CcSEcCtD
Pioglitazone—Anaemia—Cisplatin—esophageal cancer	0.000393	0.00533	CcSEcCtD
Pioglitazone—Urinary tract infection—Capecitabine—esophageal cancer	0.00039	0.00528	CcSEcCtD
Pioglitazone—Malaise—Cisplatin—esophageal cancer	0.000383	0.0052	CcSEcCtD
Pioglitazone—Haematuria—Capecitabine—esophageal cancer	0.000382	0.00518	CcSEcCtD
Pioglitazone—Myalgia—Cisplatin—esophageal cancer	0.000362	0.00491	CcSEcCtD
Pioglitazone—Hepatitis—Capecitabine—esophageal cancer	0.00036	0.00488	CcSEcCtD
Pioglitazone—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—esophageal cancer	0.000359	0.00487	CcSEcCtD
Pioglitazone—Hypoaesthesia—Capecitabine—esophageal cancer	0.000358	0.00485	CcSEcCtD
Pioglitazone—Liver function test abnormal—Methotrexate—esophageal cancer	0.000358	0.00485	CcSEcCtD
Pioglitazone—Discomfort—Cisplatin—esophageal cancer	0.000357	0.00485	CcSEcCtD
Pioglitazone—Pharyngitis—Capecitabine—esophageal cancer	0.000357	0.00484	CcSEcCtD
Pioglitazone—Urinary tract disorder—Capecitabine—esophageal cancer	0.000355	0.00482	CcSEcCtD
Pioglitazone—Oedema peripheral—Capecitabine—esophageal cancer	0.000355	0.00481	CcSEcCtD
Pioglitazone—Connective tissue disorder—Capecitabine—esophageal cancer	0.000354	0.00479	CcSEcCtD
Pioglitazone—Urethral disorder—Capecitabine—esophageal cancer	0.000353	0.00478	CcSEcCtD
Pioglitazone—Breast disorder—Methotrexate—esophageal cancer	0.00035	0.00474	CcSEcCtD
Pioglitazone—Anaphylactic shock—Cisplatin—esophageal cancer	0.000347	0.0047	CcSEcCtD
Pioglitazone—Oedema—Cisplatin—esophageal cancer	0.000347	0.0047	CcSEcCtD
Pioglitazone—Visual impairment—Capecitabine—esophageal cancer	0.000347	0.0047	CcSEcCtD
Pioglitazone—Infection—Cisplatin—esophageal cancer	0.000345	0.00467	CcSEcCtD
Pioglitazone—Nervous system disorder—Cisplatin—esophageal cancer	0.00034	0.00461	CcSEcCtD
Pioglitazone—Skin disorder—Cisplatin—esophageal cancer	0.000337	0.00457	CcSEcCtD
Pioglitazone—Eye disorder—Capecitabine—esophageal cancer	0.000336	0.00456	CcSEcCtD
Pioglitazone—Hyperhidrosis—Cisplatin—esophageal cancer	0.000335	0.00455	CcSEcCtD
Pioglitazone—Cardiac disorder—Capecitabine—esophageal cancer	0.000334	0.00453	CcSEcCtD
Pioglitazone—Immune system disorder—Capecitabine—esophageal cancer	0.000325	0.00441	CcSEcCtD
Pioglitazone—Mediastinal disorder—Capecitabine—esophageal cancer	0.000324	0.0044	CcSEcCtD
Pioglitazone—Musculoskeletal discomfort—Cisplatin—esophageal cancer	0.000316	0.00428	CcSEcCtD
Pioglitazone—Malnutrition—Capecitabine—esophageal cancer	0.000313	0.00425	CcSEcCtD
Pioglitazone—Upper respiratory tract infection—Methotrexate—esophageal cancer	0.000311	0.00422	CcSEcCtD
Pioglitazone—Dyspnoea—Cisplatin—esophageal cancer	0.000309	0.00419	CcSEcCtD
Pioglitazone—Flatulence—Capecitabine—esophageal cancer	0.000309	0.00418	CcSEcCtD
Pioglitazone—Erectile dysfunction—Methotrexate—esophageal cancer	0.000308	0.00418	CcSEcCtD
Pioglitazone—Back pain—Capecitabine—esophageal cancer	0.000303	0.00411	CcSEcCtD
Pioglitazone—Muscle spasms—Capecitabine—esophageal cancer	0.000301	0.00408	CcSEcCtD
Pioglitazone—Gastrointestinal disorder—Cisplatin—esophageal cancer	0.000299	0.00406	CcSEcCtD
Pioglitazone—Infestation NOS—Methotrexate—esophageal cancer	0.000298	0.00405	CcSEcCtD
Pioglitazone—Infestation—Methotrexate—esophageal cancer	0.000298	0.00405	CcSEcCtD
Pioglitazone—Ill-defined disorder—Capecitabine—esophageal cancer	0.000291	0.00394	CcSEcCtD
Pioglitazone—Anaemia—Capecitabine—esophageal cancer	0.00029	0.00393	CcSEcCtD
Pioglitazone—Sweating—Methotrexate—esophageal cancer	0.000286	0.00388	CcSEcCtD
Pioglitazone—Feeling abnormal—Cisplatin—esophageal cancer	0.000286	0.00387	CcSEcCtD
Pioglitazone—Haematuria—Methotrexate—esophageal cancer	0.000285	0.00386	CcSEcCtD
Pioglitazone—Malaise—Capecitabine—esophageal cancer	0.000283	0.00383	CcSEcCtD
Pioglitazone—Vertigo—Capecitabine—esophageal cancer	0.000281	0.00382	CcSEcCtD
Pioglitazone—Hypertension—Capecitabine—esophageal cancer	0.00027	0.00367	CcSEcCtD
Pioglitazone—Hepatitis—Methotrexate—esophageal cancer	0.000268	0.00363	CcSEcCtD
Pioglitazone—Arthralgia—Capecitabine—esophageal cancer	0.000267	0.00362	CcSEcCtD
Pioglitazone—Chest pain—Capecitabine—esophageal cancer	0.000267	0.00362	CcSEcCtD
Pioglitazone—Myalgia—Capecitabine—esophageal cancer	0.000267	0.00362	CcSEcCtD
Pioglitazone—Pharyngitis—Methotrexate—esophageal cancer	0.000266	0.0036	CcSEcCtD
Pioglitazone—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—esophageal cancer	0.000265	0.00359	CcSEcCtD
Pioglitazone—Urinary tract disorder—Methotrexate—esophageal cancer	0.000265	0.00359	CcSEcCtD
Pioglitazone—Discomfort—Capecitabine—esophageal cancer	0.000264	0.00357	CcSEcCtD
Pioglitazone—Urethral disorder—Methotrexate—esophageal cancer	0.000263	0.00356	CcSEcCtD
Pioglitazone—Visual impairment—Methotrexate—esophageal cancer	0.000258	0.0035	CcSEcCtD
Pioglitazone—Oedema—Capecitabine—esophageal cancer	0.000256	0.00347	CcSEcCtD
Pioglitazone—Hypersensitivity—Cisplatin—esophageal cancer	0.000256	0.00346	CcSEcCtD
Pioglitazone—Infection—Capecitabine—esophageal cancer	0.000254	0.00344	CcSEcCtD
Pioglitazone—Nervous system disorder—Capecitabine—esophageal cancer	0.000251	0.0034	CcSEcCtD
Pioglitazone—Eye disorder—Methotrexate—esophageal cancer	0.00025	0.00339	CcSEcCtD
Pioglitazone—Asthenia—Cisplatin—esophageal cancer	0.000249	0.00337	CcSEcCtD
Pioglitazone—Cardiac disorder—Methotrexate—esophageal cancer	0.000249	0.00337	CcSEcCtD
Pioglitazone—Skin disorder—Capecitabine—esophageal cancer	0.000248	0.00337	CcSEcCtD
Pioglitazone—Hyperhidrosis—Capecitabine—esophageal cancer	0.000247	0.00335	CcSEcCtD
Pioglitazone—Immune system disorder—Methotrexate—esophageal cancer	0.000242	0.00328	CcSEcCtD
Pioglitazone—Mediastinal disorder—Methotrexate—esophageal cancer	0.000241	0.00327	CcSEcCtD
Pioglitazone—Diarrhoea—Cisplatin—esophageal cancer	0.000237	0.00322	CcSEcCtD
Pioglitazone—Malnutrition—Methotrexate—esophageal cancer	0.000233	0.00316	CcSEcCtD
Pioglitazone—Musculoskeletal discomfort—Capecitabine—esophageal cancer	0.000233	0.00316	CcSEcCtD
Pioglitazone—Insomnia—Capecitabine—esophageal cancer	0.000231	0.00313	CcSEcCtD
Pioglitazone—Dyspnoea—Capecitabine—esophageal cancer	0.000228	0.00309	CcSEcCtD
Pioglitazone—Back pain—Methotrexate—esophageal cancer	0.000226	0.00306	CcSEcCtD
Pioglitazone—Gastrointestinal disorder—Capecitabine—esophageal cancer	0.000221	0.00299	CcSEcCtD
Pioglitazone—Fatigue—Capecitabine—esophageal cancer	0.00022	0.00299	CcSEcCtD
Pioglitazone—Ill-defined disorder—Methotrexate—esophageal cancer	0.000216	0.00293	CcSEcCtD
Pioglitazone—Anaemia—Methotrexate—esophageal cancer	0.000216	0.00292	CcSEcCtD
Pioglitazone—Feeling abnormal—Capecitabine—esophageal cancer	0.000211	0.00286	CcSEcCtD
Pioglitazone—Malaise—Methotrexate—esophageal cancer	0.00021	0.00285	CcSEcCtD
Pioglitazone—Vertigo—Methotrexate—esophageal cancer	0.00021	0.00284	CcSEcCtD
Pioglitazone—Urticaria—Capecitabine—esophageal cancer	0.000203	0.00275	CcSEcCtD
Pioglitazone—Arthralgia—Methotrexate—esophageal cancer	0.000199	0.00269	CcSEcCtD
Pioglitazone—Chest pain—Methotrexate—esophageal cancer	0.000199	0.00269	CcSEcCtD
Pioglitazone—Myalgia—Methotrexate—esophageal cancer	0.000199	0.00269	CcSEcCtD
Pioglitazone—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—esophageal cancer	0.000197	0.00267	CcSEcCtD
Pioglitazone—Discomfort—Methotrexate—esophageal cancer	0.000196	0.00266	CcSEcCtD
Pioglitazone—Anaphylactic shock—Methotrexate—esophageal cancer	0.00019	0.00258	CcSEcCtD
Pioglitazone—Infection—Methotrexate—esophageal cancer	0.000189	0.00256	CcSEcCtD
Pioglitazone—Hypersensitivity—Capecitabine—esophageal cancer	0.000188	0.00255	CcSEcCtD
Pioglitazone—Nervous system disorder—Methotrexate—esophageal cancer	0.000187	0.00253	CcSEcCtD
Pioglitazone—Skin disorder—Methotrexate—esophageal cancer	0.000185	0.00251	CcSEcCtD
Pioglitazone—Hyperhidrosis—Methotrexate—esophageal cancer	0.000184	0.00249	CcSEcCtD
Pioglitazone—Asthenia—Capecitabine—esophageal cancer	0.000183	0.00249	CcSEcCtD
Pioglitazone—Diarrhoea—Capecitabine—esophageal cancer	0.000175	0.00237	CcSEcCtD
Pioglitazone—Musculoskeletal discomfort—Methotrexate—esophageal cancer	0.000173	0.00235	CcSEcCtD
Pioglitazone—Insomnia—Methotrexate—esophageal cancer	0.000172	0.00233	CcSEcCtD
Pioglitazone—Dyspnoea—Methotrexate—esophageal cancer	0.00017	0.0023	CcSEcCtD
Pioglitazone—Dizziness—Capecitabine—esophageal cancer	0.000169	0.00229	CcSEcCtD
Pioglitazone—Gastrointestinal disorder—Methotrexate—esophageal cancer	0.000164	0.00223	CcSEcCtD
Pioglitazone—Fatigue—Methotrexate—esophageal cancer	0.000164	0.00222	CcSEcCtD
Pioglitazone—Headache—Capecitabine—esophageal cancer	0.00016	0.00217	CcSEcCtD
Pioglitazone—Feeling abnormal—Methotrexate—esophageal cancer	0.000157	0.00213	CcSEcCtD
Pioglitazone—Urticaria—Methotrexate—esophageal cancer	0.000151	0.00205	CcSEcCtD
Pioglitazone—Hypersensitivity—Methotrexate—esophageal cancer	0.00014	0.0019	CcSEcCtD
Pioglitazone—Asthenia—Methotrexate—esophageal cancer	0.000137	0.00185	CcSEcCtD
Pioglitazone—Diarrhoea—Methotrexate—esophageal cancer	0.00013	0.00177	CcSEcCtD
Pioglitazone—Dizziness—Methotrexate—esophageal cancer	0.000126	0.00171	CcSEcCtD
Pioglitazone—Headache—Methotrexate—esophageal cancer	0.000119	0.00162	CcSEcCtD
Pioglitazone—CYP2D6—Metabolism—SLC52A3—esophageal cancer	3.5e-05	0.000294	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism—SLC52A3—esophageal cancer	3.47e-05	0.000292	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism—BLVRB—esophageal cancer	3.47e-05	0.000292	CbGpPWpGaD
Pioglitazone—PTGS1—Metabolism—ALDOB—esophageal cancer	3.47e-05	0.000291	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism of lipids and lipoproteins—PTGS1—esophageal cancer	3.41e-05	0.000286	CbGpPWpGaD
Pioglitazone—PPARG—Gene Expression—SMAD4—esophageal cancer	3.38e-05	0.000284	CbGpPWpGaD
Pioglitazone—PTGS1—Metabolism—GAPDH—esophageal cancer	3.34e-05	0.000281	CbGpPWpGaD
Pioglitazone—CYP2C8—Metabolism—CA2—esophageal cancer	3.32e-05	0.000279	CbGpPWpGaD
Pioglitazone—SLCO1B1—Metabolism—ALDH2—esophageal cancer	3.32e-05	0.000279	CbGpPWpGaD
Pioglitazone—PTGS1—Metabolism—CRABP1—esophageal cancer	3.31e-05	0.000278	CbGpPWpGaD
Pioglitazone—CYP2C8—Metabolism of lipids and lipoproteins—CYP1B1—esophageal cancer	3.24e-05	0.000272	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism—SLC10A2—esophageal cancer	3.24e-05	0.000272	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism—CA1—esophageal cancer	3.24e-05	0.000272	CbGpPWpGaD
Pioglitazone—PPARG—Metabolism of lipids and lipoproteins—PTGS2—esophageal cancer	3.23e-05	0.000271	CbGpPWpGaD
Pioglitazone—SLCO1B3—Metabolism—HMOX1—esophageal cancer	3.21e-05	0.00027	CbGpPWpGaD
Pioglitazone—PPARG—Metabolism—CYP1B1—esophageal cancer	3.19e-05	0.000268	CbGpPWpGaD
Pioglitazone—SLCO1B1—Metabolism—GSTT1—esophageal cancer	3.16e-05	0.000265	CbGpPWpGaD
Pioglitazone—SLCO1B3—Metabolism of lipids and lipoproteins—EP300—esophageal cancer	3.15e-05	0.000264	CbGpPWpGaD
Pioglitazone—PTGS1—Metabolism—GNG7—esophageal cancer	3.15e-05	0.000264	CbGpPWpGaD
Pioglitazone—SLCO1B1—Metabolism—CYP2A6—esophageal cancer	3.12e-05	0.000262	CbGpPWpGaD
Pioglitazone—SLCO1B1—Metabolism of lipids and lipoproteins—CREBBP—esophageal cancer	3.11e-05	0.000261	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism of lipids and lipoproteins—PTGS1—esophageal cancer	3.11e-05	0.000261	CbGpPWpGaD
Pioglitazone—CYP2C8—Metabolism—ADH7—esophageal cancer	3.09e-05	0.000259	CbGpPWpGaD
Pioglitazone—CYP2C8—Metabolism—PLCE1—esophageal cancer	3.09e-05	0.000259	CbGpPWpGaD
Pioglitazone—SLCO1B3—Metabolism—ABCB1—esophageal cancer	3.08e-05	0.000259	CbGpPWpGaD
Pioglitazone—CYP2C8—Metabolism of lipids and lipoproteins—CYP19A1—esophageal cancer	3.05e-05	0.000256	CbGpPWpGaD
Pioglitazone—PPARG—Developmental Biology—EP300—esophageal cancer	3.01e-05	0.000253	CbGpPWpGaD
Pioglitazone—PPARG—Metabolism—CYP19A1—esophageal cancer	3e-05	0.000252	CbGpPWpGaD
Pioglitazone—CYP2D6—Metabolism—SLC10A2—esophageal cancer	2.98e-05	0.00025	CbGpPWpGaD
Pioglitazone—CYP2D6—Metabolism—CA1—esophageal cancer	2.98e-05	0.00025	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism—CA2—esophageal cancer	2.96e-05	0.000249	CbGpPWpGaD
Pioglitazone—SLCO1B1—Metabolism—ENO1—esophageal cancer	2.96e-05	0.000248	CbGpPWpGaD
Pioglitazone—SLCO1B1—Metabolism—PTGS1—esophageal cancer	2.96e-05	0.000248	CbGpPWpGaD
Pioglitazone—SLCO1B1—Transmembrane transport of small molecules—CREBBP—esophageal cancer	2.95e-05	0.000248	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism—SLC10A2—esophageal cancer	2.95e-05	0.000248	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism—CA1—esophageal cancer	2.95e-05	0.000248	CbGpPWpGaD
Pioglitazone—PTGS1—Metabolism—ALDH2—esophageal cancer	2.95e-05	0.000248	CbGpPWpGaD
Pioglitazone—SLCO1B1—Metabolism—PSME1—esophageal cancer	2.91e-05	0.000245	CbGpPWpGaD
Pioglitazone—SLCO1B1—Metabolism—PSME2—esophageal cancer	2.91e-05	0.000245	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism of lipids and lipoproteins—CYP1B1—esophageal cancer	2.9e-05	0.000243	CbGpPWpGaD
Pioglitazone—PTGS1—Metabolism—GSTT1—esophageal cancer	2.81e-05	0.000236	CbGpPWpGaD
Pioglitazone—PPARG—Generic Transcription Pathway—MYC—esophageal cancer	2.79e-05	0.000234	CbGpPWpGaD
Pioglitazone—PTGS1—Metabolism—CYP2A6—esophageal cancer	2.78e-05	0.000233	CbGpPWpGaD
Pioglitazone—PTGS1—Metabolism of lipids and lipoproteins—CREBBP—esophageal cancer	2.76e-05	0.000232	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism—ADH7—esophageal cancer	2.75e-05	0.000231	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism—PLCE1—esophageal cancer	2.75e-05	0.000231	CbGpPWpGaD
Pioglitazone—PPARG—Metabolism—HMOX1—esophageal cancer	2.74e-05	0.00023	CbGpPWpGaD
Pioglitazone—CYP2D6—Metabolism—CA2—esophageal cancer	2.73e-05	0.000229	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism of lipids and lipoproteins—CYP19A1—esophageal cancer	2.72e-05	0.000229	CbGpPWpGaD
Pioglitazone—CYP2C8—Metabolism—ADH1B—esophageal cancer	2.71e-05	0.000227	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism—CA2—esophageal cancer	2.7e-05	0.000227	CbGpPWpGaD
Pioglitazone—PPARG—Metabolism of lipids and lipoproteins—EP300—esophageal cancer	2.69e-05	0.000226	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism of lipids and lipoproteins—CYP1B1—esophageal cancer	2.64e-05	0.000222	CbGpPWpGaD
Pioglitazone—PTGS1—Metabolism—ENO1—esophageal cancer	2.63e-05	0.000221	CbGpPWpGaD
Pioglitazone—PPARG—Metabolism—ABCB1—esophageal cancer	2.63e-05	0.000221	CbGpPWpGaD
Pioglitazone—PTGS1—Metabolism—PSME1—esophageal cancer	2.59e-05	0.000218	CbGpPWpGaD
Pioglitazone—PTGS1—Metabolism—PSME2—esophageal cancer	2.59e-05	0.000218	CbGpPWpGaD
Pioglitazone—CYP2C8—Metabolism—TYMP—esophageal cancer	2.59e-05	0.000217	CbGpPWpGaD
Pioglitazone—PPARG—Developmental Biology—EGFR—esophageal cancer	2.56e-05	0.000215	CbGpPWpGaD
Pioglitazone—SLCO1B1—Metabolism of lipids and lipoproteins—PTGS2—esophageal cancer	2.54e-05	0.000214	CbGpPWpGaD
Pioglitazone—CYP2D6—Metabolism—PLCE1—esophageal cancer	2.53e-05	0.000213	CbGpPWpGaD
Pioglitazone—CYP2D6—Metabolism—ADH7—esophageal cancer	2.53e-05	0.000213	CbGpPWpGaD
Pioglitazone—CYP2C8—Metabolism—CYP26A1—esophageal cancer	2.52e-05	0.000211	CbGpPWpGaD
Pioglitazone—SLCO1B1—Metabolism—CYP1B1—esophageal cancer	2.51e-05	0.000211	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism—PLCE1—esophageal cancer	2.51e-05	0.000211	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism—ADH7—esophageal cancer	2.51e-05	0.000211	CbGpPWpGaD
Pioglitazone—PPARG—Gene Expression—NOTCH1—esophageal cancer	2.49e-05	0.000209	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism of lipids and lipoproteins—CYP19A1—esophageal cancer	2.48e-05	0.000208	CbGpPWpGaD
Pioglitazone—CYP2C8—Metabolism—ALOX15—esophageal cancer	2.45e-05	0.000206	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism—ADH1B—esophageal cancer	2.42e-05	0.000203	CbGpPWpGaD
Pioglitazone—SLCO1B1—Metabolism—CYP19A1—esophageal cancer	2.36e-05	0.000198	CbGpPWpGaD
Pioglitazone—CYP2C8—Metabolism—TPI1—esophageal cancer	2.34e-05	0.000196	CbGpPWpGaD
Pioglitazone—CYP2C8—Metabolism—GSTO1—esophageal cancer	2.34e-05	0.000196	CbGpPWpGaD
Pioglitazone—SLCO1B3—Metabolism of lipids and lipoproteins—PIK3CA—esophageal cancer	2.33e-05	0.000196	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism—TYMP—esophageal cancer	2.31e-05	0.000194	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—SLC52A3—esophageal cancer	2.29e-05	0.000192	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—BLVRB—esophageal cancer	2.29e-05	0.000192	CbGpPWpGaD
Pioglitazone—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—esophageal cancer	2.26e-05	0.00019	CbGpPWpGaD
Pioglitazone—PPARG—Gene Expression—CREBBP—esophageal cancer	2.26e-05	0.00019	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism—CYP26A1—esophageal cancer	2.25e-05	0.000189	CbGpPWpGaD
Pioglitazone—CYP2C8—Metabolism—ALDOB—esophageal cancer	2.24e-05	0.000188	CbGpPWpGaD
Pioglitazone—PTGS1—Metabolism—CYP1B1—esophageal cancer	2.24e-05	0.000188	CbGpPWpGaD
Pioglitazone—CYP2D6—Metabolism—ADH1B—esophageal cancer	2.22e-05	0.000187	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism—ADH1B—esophageal cancer	2.2e-05	0.000185	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism—ALOX15—esophageal cancer	2.19e-05	0.000184	CbGpPWpGaD
Pioglitazone—CYP2C8—Metabolism—GAPDH—esophageal cancer	2.16e-05	0.000181	CbGpPWpGaD
Pioglitazone—SLCO1B1—Metabolism—HMOX1—esophageal cancer	2.16e-05	0.000181	CbGpPWpGaD
Pioglitazone—CYP2C8—Metabolism—CRABP1—esophageal cancer	2.14e-05	0.00018	CbGpPWpGaD
Pioglitazone—CYP2D6—Metabolism—TYMP—esophageal cancer	2.12e-05	0.000178	CbGpPWpGaD
Pioglitazone—SLCO1B1—Metabolism of lipids and lipoproteins—EP300—esophageal cancer	2.12e-05	0.000178	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism—TYMP—esophageal cancer	2.1e-05	0.000177	CbGpPWpGaD
Pioglitazone—PTGS1—Metabolism—CYP19A1—esophageal cancer	2.1e-05	0.000177	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism—TPI1—esophageal cancer	2.09e-05	0.000175	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism—GSTO1—esophageal cancer	2.09e-05	0.000175	CbGpPWpGaD
Pioglitazone—SLCO1B1—Metabolism—ABCB1—esophageal cancer	2.07e-05	0.000174	CbGpPWpGaD
Pioglitazone—CYP2D6—Metabolism—CYP26A1—esophageal cancer	2.07e-05	0.000173	CbGpPWpGaD
Pioglitazone—SLCO1B3—Metabolism—CREBBP—esophageal cancer	2.06e-05	0.000173	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism—CYP26A1—esophageal cancer	2.05e-05	0.000172	CbGpPWpGaD
Pioglitazone—CYP2C8—Metabolism—GNG7—esophageal cancer	2.03e-05	0.000171	CbGpPWpGaD
Pioglitazone—CYP2D6—Metabolism—ALOX15—esophageal cancer	2.01e-05	0.000169	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism—ALDOB—esophageal cancer	2e-05	0.000168	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism—ALOX15—esophageal cancer	2e-05	0.000168	CbGpPWpGaD
Pioglitazone—PPARG—Metabolism of lipids and lipoproteins—PIK3CA—esophageal cancer	1.99e-05	0.000167	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—CA1—esophageal cancer	1.95e-05	0.000164	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—SLC10A2—esophageal cancer	1.95e-05	0.000164	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism—GAPDH—esophageal cancer	1.93e-05	0.000162	CbGpPWpGaD
Pioglitazone—CYP2D6—Metabolism—GSTO1—esophageal cancer	1.92e-05	0.000161	CbGpPWpGaD
Pioglitazone—CYP2D6—Metabolism—TPI1—esophageal cancer	1.92e-05	0.000161	CbGpPWpGaD
Pioglitazone—PTGS1—Metabolism—HMOX1—esophageal cancer	1.92e-05	0.000161	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism—CRABP1—esophageal cancer	1.91e-05	0.00016	CbGpPWpGaD
Pioglitazone—CYP2C8—Metabolism—ALDH2—esophageal cancer	1.91e-05	0.00016	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism—TPI1—esophageal cancer	1.9e-05	0.00016	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism—GSTO1—esophageal cancer	1.9e-05	0.00016	CbGpPWpGaD
Pioglitazone—PTGS1—Metabolism of lipids and lipoproteins—EP300—esophageal cancer	1.88e-05	0.000158	CbGpPWpGaD
Pioglitazone—SLCO1B3—Metabolism—NOS3—esophageal cancer	1.84e-05	0.000155	CbGpPWpGaD
Pioglitazone—PTGS1—Metabolism—ABCB1—esophageal cancer	1.84e-05	0.000155	CbGpPWpGaD
Pioglitazone—CYP2D6—Metabolism—ALDOB—esophageal cancer	1.84e-05	0.000155	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism—ALDOB—esophageal cancer	1.82e-05	0.000153	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism—GNG7—esophageal cancer	1.82e-05	0.000152	CbGpPWpGaD
Pioglitazone—CYP2C8—Metabolism—GSTT1—esophageal cancer	1.81e-05	0.000152	CbGpPWpGaD
Pioglitazone—CYP2C8—Metabolism—CYP2A6—esophageal cancer	1.79e-05	0.000151	CbGpPWpGaD
Pioglitazone—CYP2C8—Metabolism of lipids and lipoproteins—CREBBP—esophageal cancer	1.79e-05	0.00015	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—CA2—esophageal cancer	1.78e-05	0.00015	CbGpPWpGaD
Pioglitazone—CYP2D6—Metabolism—GAPDH—esophageal cancer	1.77e-05	0.000149	CbGpPWpGaD
Pioglitazone—PPARG—Metabolism—CREBBP—esophageal cancer	1.76e-05	0.000148	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism—GAPDH—esophageal cancer	1.76e-05	0.000147	CbGpPWpGaD
Pioglitazone—CYP2D6—Metabolism—CRABP1—esophageal cancer	1.76e-05	0.000147	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism—CRABP1—esophageal cancer	1.74e-05	0.000146	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism—ALDH2—esophageal cancer	1.7e-05	0.000143	CbGpPWpGaD
Pioglitazone—CYP2C8—Metabolism—ENO1—esophageal cancer	1.7e-05	0.000143	CbGpPWpGaD
Pioglitazone—CYP2C8—Metabolism—PTGS1—esophageal cancer	1.7e-05	0.000143	CbGpPWpGaD
Pioglitazone—SLCO1B3—Metabolism—PTGS2—esophageal cancer	1.69e-05	0.000142	CbGpPWpGaD
Pioglitazone—CYP2C8—Metabolism—PSME2—esophageal cancer	1.67e-05	0.000141	CbGpPWpGaD
Pioglitazone—CYP2C8—Metabolism—PSME1—esophageal cancer	1.67e-05	0.000141	CbGpPWpGaD
Pioglitazone—CYP2D6—Metabolism—GNG7—esophageal cancer	1.67e-05	0.00014	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—PLCE1—esophageal cancer	1.66e-05	0.000139	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—ADH7—esophageal cancer	1.66e-05	0.000139	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism—GNG7—esophageal cancer	1.66e-05	0.000139	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism—GSTT1—esophageal cancer	1.62e-05	0.000136	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism—CYP2A6—esophageal cancer	1.6e-05	0.000134	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism of lipids and lipoproteins—CREBBP—esophageal cancer	1.59e-05	0.000134	CbGpPWpGaD
Pioglitazone—PPARG—Metabolism—NOS3—esophageal cancer	1.57e-05	0.000132	CbGpPWpGaD
Pioglitazone—SLCO1B1—Metabolism of lipids and lipoproteins—PIK3CA—esophageal cancer	1.57e-05	0.000131	CbGpPWpGaD
Pioglitazone—CYP2D6—Metabolism—ALDH2—esophageal cancer	1.57e-05	0.000131	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism—ALDH2—esophageal cancer	1.55e-05	0.00013	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism—PTGS1—esophageal cancer	1.52e-05	0.000127	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism—ENO1—esophageal cancer	1.52e-05	0.000127	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism—PSME2—esophageal cancer	1.49e-05	0.000125	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism—PSME1—esophageal cancer	1.49e-05	0.000125	CbGpPWpGaD
Pioglitazone—CYP2D6—Metabolism—GSTT1—esophageal cancer	1.49e-05	0.000125	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism—GSTT1—esophageal cancer	1.48e-05	0.000124	CbGpPWpGaD
Pioglitazone—CYP2D6—Metabolism—CYP2A6—esophageal cancer	1.47e-05	0.000124	CbGpPWpGaD
Pioglitazone—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—esophageal cancer	1.46e-05	0.000123	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism—CYP2A6—esophageal cancer	1.46e-05	0.000122	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism of lipids and lipoproteins—CREBBP—esophageal cancer	1.45e-05	0.000122	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—ADH1B—esophageal cancer	1.45e-05	0.000122	CbGpPWpGaD
Pioglitazone—CYP2C8—Metabolism—CYP1B1—esophageal cancer	1.44e-05	0.000121	CbGpPWpGaD
Pioglitazone—PPARG—Metabolism—PTGS2—esophageal cancer	1.44e-05	0.000121	CbGpPWpGaD
Pioglitazone—SLCO1B3—Metabolism—EP300—esophageal cancer	1.4e-05	0.000118	CbGpPWpGaD
Pioglitazone—CYP2D6—Metabolism—PTGS1—esophageal cancer	1.4e-05	0.000117	CbGpPWpGaD
Pioglitazone—CYP2D6—Metabolism—ENO1—esophageal cancer	1.4e-05	0.000117	CbGpPWpGaD
Pioglitazone—PTGS1—Metabolism of lipids and lipoproteins—PIK3CA—esophageal cancer	1.39e-05	0.000117	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—TYMP—esophageal cancer	1.39e-05	0.000117	CbGpPWpGaD
Pioglitazone—SLCO1B1—Metabolism—CREBBP—esophageal cancer	1.38e-05	0.000116	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism—ENO1—esophageal cancer	1.38e-05	0.000116	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism—PTGS1—esophageal cancer	1.38e-05	0.000116	CbGpPWpGaD
Pioglitazone—CYP2D6—Metabolism—PSME2—esophageal cancer	1.37e-05	0.000115	CbGpPWpGaD
Pioglitazone—CYP2D6—Metabolism—PSME1—esophageal cancer	1.37e-05	0.000115	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism—PSME1—esophageal cancer	1.36e-05	0.000114	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism—PSME2—esophageal cancer	1.36e-05	0.000114	CbGpPWpGaD
Pioglitazone—CYP2C8—Metabolism—CYP19A1—esophageal cancer	1.36e-05	0.000114	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—CYP26A1—esophageal cancer	1.35e-05	0.000113	CbGpPWpGaD
Pioglitazone—PPARG—Gene Expression—MYC—esophageal cancer	1.34e-05	0.000113	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—ALOX15—esophageal cancer	1.32e-05	0.00011	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—esophageal cancer	1.31e-05	0.00011	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism—CYP1B1—esophageal cancer	1.29e-05	0.000108	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—TPI1—esophageal cancer	1.26e-05	0.000105	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—GSTO1—esophageal cancer	1.26e-05	0.000105	CbGpPWpGaD
Pioglitazone—CYP2C8—Metabolism—HMOX1—esophageal cancer	1.24e-05	0.000104	CbGpPWpGaD
Pioglitazone—SLCO1B1—Metabolism—NOS3—esophageal cancer	1.24e-05	0.000104	CbGpPWpGaD
Pioglitazone—PTGS1—Metabolism—CREBBP—esophageal cancer	1.23e-05	0.000103	CbGpPWpGaD
Pioglitazone—CYP2C8—Metabolism of lipids and lipoproteins—EP300—esophageal cancer	1.22e-05	0.000102	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism—CYP19A1—esophageal cancer	1.21e-05	0.000102	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—ALDOB—esophageal cancer	1.2e-05	0.000101	CbGpPWpGaD
Pioglitazone—PPARG—Metabolism—EP300—esophageal cancer	1.2e-05	0.0001	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—esophageal cancer	1.19e-05	9.99e-05	CbGpPWpGaD
Pioglitazone—CYP2C8—Metabolism—ABCB1—esophageal cancer	1.19e-05	9.99e-05	CbGpPWpGaD
Pioglitazone—CYP2D6—Metabolism—CYP1B1—esophageal cancer	1.19e-05	9.96e-05	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism—CYP1B1—esophageal cancer	1.18e-05	9.87e-05	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—GAPDH—esophageal cancer	1.16e-05	9.73e-05	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—CRABP1—esophageal cancer	1.15e-05	9.64e-05	CbGpPWpGaD
Pioglitazone—SLCO1B1—Metabolism—PTGS2—esophageal cancer	1.13e-05	9.51e-05	CbGpPWpGaD
Pioglitazone—CYP2D6—Metabolism—CYP19A1—esophageal cancer	1.12e-05	9.36e-05	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism—HMOX1—esophageal cancer	1.11e-05	9.29e-05	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism—CYP19A1—esophageal cancer	1.11e-05	9.28e-05	CbGpPWpGaD
Pioglitazone—PTGS1—Metabolism—NOS3—esophageal cancer	1.1e-05	9.25e-05	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—GNG7—esophageal cancer	1.09e-05	9.17e-05	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism of lipids and lipoproteins—EP300—esophageal cancer	1.09e-05	9.11e-05	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism—ABCB1—esophageal cancer	1.06e-05	8.92e-05	CbGpPWpGaD
Pioglitazone—SLCO1B3—Metabolism—PIK3CA—esophageal cancer	1.04e-05	8.71e-05	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—ALDH2—esophageal cancer	1.02e-05	8.59e-05	CbGpPWpGaD
Pioglitazone—CYP2D6—Metabolism—HMOX1—esophageal cancer	1.02e-05	8.54e-05	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism—HMOX1—esophageal cancer	1.01e-05	8.47e-05	CbGpPWpGaD
Pioglitazone—PTGS1—Metabolism—PTGS2—esophageal cancer	1.01e-05	8.46e-05	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism of lipids and lipoproteins—EP300—esophageal cancer	9.9e-06	8.31e-05	CbGpPWpGaD
Pioglitazone—CYP2D6—Metabolism—ABCB1—esophageal cancer	9.77e-06	8.2e-05	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—GSTT1—esophageal cancer	9.73e-06	8.17e-05	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism—ABCB1—esophageal cancer	9.68e-06	8.13e-05	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—CYP2A6—esophageal cancer	9.62e-06	8.08e-05	CbGpPWpGaD
Pioglitazone—SLCO1B1—Metabolism—EP300—esophageal cancer	9.43e-06	7.91e-05	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—PTGS1—esophageal cancer	9.12e-06	7.66e-05	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—ENO1—esophageal cancer	9.12e-06	7.66e-05	CbGpPWpGaD
Pioglitazone—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—esophageal cancer	9e-06	7.55e-05	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—PSME2—esophageal cancer	8.99e-06	7.55e-05	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—PSME1—esophageal cancer	8.99e-06	7.55e-05	CbGpPWpGaD
Pioglitazone—PPARG—Metabolism—PIK3CA—esophageal cancer	8.85e-06	7.43e-05	CbGpPWpGaD
Pioglitazone—PTGS1—Metabolism—EP300—esophageal cancer	8.38e-06	7.04e-05	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—esophageal cancer	8.03e-06	6.74e-05	CbGpPWpGaD
Pioglitazone—CYP2C8—Metabolism—CREBBP—esophageal cancer	7.95e-06	6.68e-05	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—CYP1B1—esophageal cancer	7.76e-06	6.51e-05	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—esophageal cancer	7.32e-06	6.15e-05	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—CYP19A1—esophageal cancer	7.29e-06	6.12e-05	CbGpPWpGaD
Pioglitazone—CYP2C8—Metabolism—NOS3—esophageal cancer	7.12e-06	5.98e-05	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism—CREBBP—esophageal cancer	7.1e-06	5.96e-05	CbGpPWpGaD
Pioglitazone—SLCO1B1—Metabolism—PIK3CA—esophageal cancer	6.97e-06	5.85e-05	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—HMOX1—esophageal cancer	6.65e-06	5.59e-05	CbGpPWpGaD
Pioglitazone—CYP2D6—Metabolism—CREBBP—esophageal cancer	6.53e-06	5.48e-05	CbGpPWpGaD
Pioglitazone—CYP2C8—Metabolism—PTGS2—esophageal cancer	6.51e-06	5.47e-05	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism—CREBBP—esophageal cancer	6.47e-06	5.43e-05	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—ABCB1—esophageal cancer	6.39e-06	5.36e-05	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism—NOS3—esophageal cancer	6.36e-06	5.34e-05	CbGpPWpGaD
Pioglitazone—PTGS1—Metabolism—PIK3CA—esophageal cancer	6.2e-06	5.21e-05	CbGpPWpGaD
Pioglitazone—CYP2D6—Metabolism—NOS3—esophageal cancer	5.85e-06	4.91e-05	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism—PTGS2—esophageal cancer	5.81e-06	4.88e-05	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism—NOS3—esophageal cancer	5.79e-06	4.87e-05	CbGpPWpGaD
Pioglitazone—CYP2C8—Metabolism—EP300—esophageal cancer	5.42e-06	4.55e-05	CbGpPWpGaD
Pioglitazone—CYP2D6—Metabolism—PTGS2—esophageal cancer	5.35e-06	4.49e-05	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism—PTGS2—esophageal cancer	5.3e-06	4.45e-05	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism—EP300—esophageal cancer	4.83e-06	4.06e-05	CbGpPWpGaD
Pioglitazone—CYP2D6—Metabolism—EP300—esophageal cancer	4.45e-06	3.73e-05	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism—EP300—esophageal cancer	4.41e-06	3.7e-05	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—CREBBP—esophageal cancer	4.27e-06	3.58e-05	CbGpPWpGaD
Pioglitazone—CYP2C8—Metabolism—PIK3CA—esophageal cancer	4.01e-06	3.36e-05	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—NOS3—esophageal cancer	3.82e-06	3.21e-05	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism—PIK3CA—esophageal cancer	3.58e-06	3e-05	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—PTGS2—esophageal cancer	3.5e-06	2.93e-05	CbGpPWpGaD
Pioglitazone—CYP2D6—Metabolism—PIK3CA—esophageal cancer	3.29e-06	2.76e-05	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism—PIK3CA—esophageal cancer	3.26e-06	2.74e-05	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—EP300—esophageal cancer	2.91e-06	2.44e-05	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—PIK3CA—esophageal cancer	2.15e-06	1.81e-05	CbGpPWpGaD
